<DOC>
	<DOC>NCT00130481</DOC>
	<brief_summary>The purpose of this study is to determine if Atorvastatin can improve blood vessel stiffness and blood vessel function in children 10-18 years old with Type 1 and Type 2 diabetes. Subjects will receive atorvastatin 20mg or placebo daily for 3 months and will then switch therapies for the next 3 months. Hypothesis: Atorvastatin will improve blood vessel function by decreasing arterial stiffness and improving blood flow.</brief_summary>
	<brief_title>Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Type 1 Diabetes Mellitus (T1DM) or Type 2 Diabetes Mellitus (T2DM) for more than 1 year Age 1018 years. Cardiovascular disease (CVD) Liver disease Pregnancy Use of cholesterol or triglyceride lowering drugs Perceived inability to comply with the study protocol Endocrinopathy other than diabetes</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Children</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Arterial Compliance</keyword>
	<keyword>Physiology Cardiovascular Endothelium</keyword>
</DOC>